Assessing the neuroprotective and remyelinating potential of treatments in acute optic neuritis

Takeaway

  • Acute optic neuritis (AON) appeared to be an appropriate condition to evaluate the neuroprotective and remyelinating potential of a therapy for multiple sclerosis (MS).

Why this matters

    Neuroprotective and remyelinating drugs have been used to treat MS, a demyelinating and neurodegenerative disease. The results of this study showed that potential neuroprotective and remyelinating treatments can be evaluated in individuals with AON which will help to expand the number of available treatments for MS.